安格曼综合征：唤醒父源基因的药物。
Angelman syndrome: Drugs to awaken a paternal gene.
出版信息
Nature. 2011 Dec 21;481(7380):150-2. doi: 10.1038/nature10784.
Abstract
Mutations in the maternal copy of the gene cause a neurodevelopmental disorder known as Angelman syndrome. Drugs that activate the normally silenced paternal copy of this gene may be of therapeutic value.
摘要
该基因的母源拷贝中的突变会导致一种称为安格曼综合征的神经发育障碍。激活该基因通常沉默的父源拷贝的药物可能具有治疗价值。
相似文献
1
Angelman syndrome: Drugs to awaken a paternal gene.安格曼综合征：唤醒父源基因的药物。
Nature. 2011 Dec 21;481(7380):150-2. doi: 10.1038/nature10784.
2
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.拓扑异构酶抑制剂使神经元中 Ube3a 的休眠等位基因重新活跃。
Nature. 2011 Dec 21;481(7380):185-9. doi: 10.1038/nature10726.
3
Study suggests new topoisomerase inhibitors are capable of unsilencing dormant UBE3A in mouse neurons.研究表明，新型拓扑异构酶抑制剂能够使小鼠神经元中处于沉默状态的UBE3A重新激活。
Expert Rev Proteomics. 2012;9(1):5. doi: 10.1586/epr.12.3.
4
Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant gene associated with Angelman syndrome.吲哚异喹啉类拓扑异构酶 I 抑制剂的鉴定及构效关系研究及其在沉默与 Angelman 综合征相关的休眠基因中的应用。
Mol Autism. 2018 Aug 17;9:45. doi: 10.1186/s13229-018-0228-2. eCollection 2018.
5
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.通过靶向长非编码 RNA 治疗 Angelman 综合征。
Nature. 2015 Feb 19;518(7539):409-12. doi: 10.1038/nature13975. Epub 2014 Dec 1.
6
Human Cerebral Organoids Reveal Early Spatiotemporal Dynamics and Pharmacological Responses of UBE3A.人类大脑类器官揭示 UBE3A 的早期时空动力学和药物反应
Stem Cell Reports. 2020 Oct 13;15(4):845-854. doi: 10.1016/j.stemcr.2020.08.006. Epub 2020 Sep 10.
7
Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors.天使综合征的基因治疗：当代方法与未来努力
Curr Gene Ther. 2020;19(6):359-366. doi: 10.2174/1566523220666200107151025.
8
Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.天使综合征衍生的神经元表现出父源UBE3A沉默的延迟发生。
Sci Rep. 2016 Aug 3;6:30792. doi: 10.1038/srep30792.
9
Silenced genes turned on to treat Angelman's syndrome.沉默基因被激活用于治疗天使综合征。
Lab Anim (NY). 2012 Jan 20;41(2):34. doi: 10.1038/laban0212-34b.
10
Pharmacological therapies for Angelman syndrome.天使综合征的药物治疗
Wien Med Wochenschr. 2017 Jun;167(9-10):205-218. doi: 10.1007/s10354-015-0408-z. Epub 2016 Jan 12.
引用本文的文献
1
Acute administration of lovastatin had no pronounced effect on motor abilities, motor coordination, gait nor simple cognition in a mouse model of Angelman syndrome.在天使综合征小鼠模型中，急性给予洛伐他汀对运动能力、运动协调性、步态或简单认知均无显著影响。
J Neurodev Disord. 2025 May 17;17(1):27. doi: 10.1186/s11689-025-09616-6.
2
Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.靶向TrkB/PSD-95信号通路的拟肽抑制剂可改善天使综合征小鼠模型的认知和癫痫发作结果。
Neuropsychopharmacology. 2025 Apr;50(5):772-782. doi: 10.1038/s41386-024-02020-z. Epub 2024 Nov 7.
3
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.神经发育障碍性疾病安格曼综合征的新兴基因与小分子治疗策略。
Neurotherapeutics. 2021 Jul;18(3):1535-1547. doi: 10.1007/s13311-021-01082-x. Epub 2021 Sep 15.
4
Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.泛素连接酶 E3A 基因完全缺失的 Angelman 综合征大鼠模型中的转化结果。
Transl Psychiatry. 2020 Jan 27;10(1):39. doi: 10.1038/s41398-020-0720-2.
5
Allele and dosage specificity of the Peg3 imprinted domain.等位基因和 Peg3 印记域的剂量特异性。
PLoS One. 2018 May 7;13(5):e0197069. doi: 10.1371/journal.pone.0197069. eCollection 2018.
6
Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.泛素蛋白连接酶E3A恢复在小鼠天使综合征模型中确定了不同的发育窗口。
J Clin Invest. 2015 May;125(5):2069-76. doi: 10.1172/JCI80554. Epub 2015 Apr 13.
7
Topoisomerase 1 inhibition reversibly impairs synaptic function.拓扑异构酶1抑制作用会可逆地损害突触功能。
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17290-5. doi: 10.1073/pnas.1413204111. Epub 2014 Nov 17.
8
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation.R 环在 Snord116 处的形成介导拓扑替康抑制 Ube3a-反义链和等位基因特异性染色质去凝聚。
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13938-43. doi: 10.1073/pnas.1305426110. Epub 2013 Aug 5.
9
Synaptic plasticity in mouse models of autism spectrum disorders.自闭症谱系障碍小鼠模型中的突触可塑性。
Korean J Physiol Pharmacol. 2012 Dec;16(6):369-78. doi: 10.4196/kjpp.2012.16.6.369. Epub 2012 Dec 10.
本文引用的文献
1
A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome.Angelman 综合征中促甲基化膳食补充剂的治疗试验。
Am J Med Genet A. 2011 Dec;155A(12):2956-63. doi: 10.1002/ajmg.a.34297. Epub 2011 Oct 14.
2
Clinical and genetic aspects of Angelman syndrome.安格曼综合征的临床与遗传方面。
Genet Med. 2010 Jul;12(7):385-95. doi: 10.1097/GIM.0b013e3181def138.
3
Reversal of neurological defects in a mouse model of Rett syndrome.雷特综合征小鼠模型中神经缺陷的逆转
Science. 2007 Feb 23;315(5815):1143-7. doi: 10.1126/science.1138389. Epub 2007 Feb 8.
4
Intrathecal topotecan in adult patients with neoplastic meningitis.鞘内注射拓扑替康用于成年肿瘤性脑膜炎患者。
Am J Health Syst Pharm. 2006 Nov 1;63(21):2083-6. doi: 10.2146/ajhp060165.
5
Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome.安吉尔曼智力发育迟缓综合征小鼠模型中海马钙/钙调蛋白依赖性蛋白激酶II的紊乱
J Neurosci. 2003 Apr 1;23(7):2634-44. doi: 10.1523/JNEUROSCI.23-07-02634.2003.
Zotero 插件